维普期刊资源整合服务平台（V6.5）

243篇 您的检索式：作者名="Uramoto"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy显示文摘	Hiroto Izumi Takayuki Torigoe Hiroshi Ishiguchi Hidetaka Uramoto Yoichiro Yoshida Mizuho Tanabe Tomoko Ise Tadashi Murakami Takeshi Yoshida Minoru Nomoto Kimitoshi Kohno	2003	Cancer Treatment Reviews2003，，6：	2
2	Trends in the incidence and mortality of systernic lupus erythematosus,1950-1992显示文摘	Uramoto KM Michet CJ Thumboo J	1999	Arthritis Rheum1999，42，1：	1
3	A new mechanism for primary resistance to gefitinib in lung adenocarcinoma: the role of a novel G796A mutation in exon 20 of EGFR 显示文摘	Uramoto H Uchimni T Izumi H	2007	Anticancer Res2007，27，4：	1
4	A new mechanism for primary resistance to gefitinib in lung adenocarcinoma: the role of a novel G796A mutation in exon 20 of EGFR 显示文摘	Uramoto H Uchiumi T Izumi H	2007	Anticancer Res2007，27，4：	1
5	Expression of se- lected gene for acquired drug resistance to EGFR-TKI in lung ad- 显示文摘	Uramoto H Shimokawa H Hanagiri T	2011	Lung Cancer2011，73，3：	1
6	Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer显示文摘	Hanagiri T Sugio K Uramoto H	2007	Surg Today2007，37，7：	1
7	Altered expression of amylold precursors proteins after traumatic brain injury in rats:in situ hybridization and immunohistochemical study 显示文摘	Masumura M Hata R Uramoto H	2000	J Neurotrauma2000，17，：	1
8	Acquired resistance to gefitinib: The contribution of mechanisms other than the T790M, MET, and HGF status显示文摘	Takamitsu Onitsuka Hidetaka Uramoto Naohiro Nose Mitsuhiro Takenoyama Takeshi Hanagiri Kenji Sugio Kosei Yasumoto	2009	Lung Cancer2009，，2：	1
9	Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma显示文摘	Uramoto H Shimokawa H Hanagiri T	2011	Lung Cancer2011，，03：	1
10	Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer显示文摘	Uramoto H Mitsudomi T	2007	Br J Cancer2007，96，6：	1
11	Transport of phenol from aqueous solution to organic solvent through a microporous membrane made of crosslinkedpoly(4-vinylpyridine)显示文摘	Uramoto H Kawabata N Teramoto M	1991	Journal of Membrane Science1991，62，2：	1
12	Which biomarker predicts benefit from EGFRTKI treatment for patients with lung cancer显示文摘	Uramoto H Mitsudomi T	2007	Br J Cancer2007，96，6：	1
13	Acquired resistance to gefitinib: The contribution of mechanisms other than the T790M, MET, and HGF status显示文摘	Takamitsu Onitsuka Hidetaka Uramoto Naohiro Nose Mitsuhiro Takenoyama Takeshi Hanagiri Kenji Sugio Kosei Yasumoto	2009	Lung Cancer2009，，2：	1
14	A new mechanism for primary resistance to gefitinib in lung adenocarcinoma: the role of a novel G796A mutatin in exon 20 of EGFR 显示文摘	Uramoto H Uchiumi T Izumi H	2007	Anticancer Res2007，27，4：	1
15	Cytochrome P450 expression (CYP) in non-small cell lung cancer显示文摘	Tsunehiro Oyama Kenji Sugio Hidetaka Uramoto	2007	Frontiers in Bioscience2007，12，：	1
16	TS,DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed显示文摘	Uramoto H Onitsuka T Shimokawa H		0，，：	1
17	Epithelial- esenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma 显示文摘	URAMOTO H IWATA T ONITSUKA T	2010	Anticancer Res2010，30，7：	1
18	Expression of endo- plasmic reticulum molecular chaperone GRP78 in human lung cancer and its clinical significance 显示文摘	Uramoto H Sugio K Oyama T	2005	Lung cancer2005，49，：	1
19	Trends in the incidence and mortality of systemic lupus erythe matosus,1950-1992显示文摘	Uramoto KM Michet CJ Thumboo J	1999	ArthritisRheum1999，42，：	1
20	Expression of endo- plasmic reticulum molecular chaperone G RP78 in human lung cancer and its clinical significance显示文摘	URAMOTO H SUGIO K OYAMA T	2005	Lung Cancer2005，49，1：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示